HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma

Author： Midulla Cecilia  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.33, Iss.5, 2012-10, pp. : 1291-1298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer

By                  

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2481-2487

Spandidos Publications

Access to resources Recommend Favorite

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

By Chi D.S.   Liao J.B.   Leon L.F.   Venkatraman E.S.   Hensley M.L.   Bhaskaran D.   Hoskins W.J.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 532-537

Elsevier

Access to resources Recommend Favorite

Evaluation of Chemoresistance Markers in Women with Epithelial Ovarian Carcinoma

By Goff B.A.   Paley P.J.   Greer B.E.   Gown A.M.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 18-24

Elsevier

Access to resources Recommend Favorite

Cancer-Associated Retinopathy in a Patient with Advanced Epithelial Ovarian Carcinoma

By Harmon J.P.   Purvin V.A.   Guy J.   Aptsiauri N.   Sutton G.P.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 430-432

Elsevier

Access to resources Recommend Favorite

Aflibercept in epithelial ovarian carcinoma

By Moroney John W   Sood Anil K   Coleman Robert L  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 591-600

Future Medicine

Access to resources Recommend Favorite